No results for ‘’
Ajanta Pharma Ltd
₹3563.60
(1.80%)
Sun, 27 Sept 2026, 11:51 pm
Ajanta Pharma Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 66.25 | 66.25 | 66.25 | 66.26 | 66.26 |
| FII | 8.26 | 7.98 | 8.53 | 8.86 | 8.86 |
| DII | 18.37 | 18.58 | 17.90 | 17.50 | 17.48 |
| Public | 7.12 | 7.19 | 7.32 | 7.38 | 7.39 |
| Government | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Ajanta Pharma Ltd Shareholding Pattern
The Ajanta Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Ajanta Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Ajanta Pharma Ltd (NSE: AJANTPHARM, BSE: 532331) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Ajanta Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Ajanta Pharma Ltd Shareholding Pattern (Latest)
The latest Ajanta Pharma Ltd shareholding for Mar 2026 is:
- Promoters: 66.25%
- FII: 8.26%
- DII: 18.37%
- Public: 7.12%
- Government: 0.01%
Promoter holding in Ajanta Pharma Ltd remains stable, reflecting consistent long-term commitment.
Ajanta Pharma Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Ajanta Pharma Ltd.
- Mar 2026: 66.25%
- Dec 2025: 66.25%
- Sept 2025: 66.25%
- Jun 2025: 66.26%
- Mar 2025: 66.26%
Promoter stake remains largely stable, showing consistent ownership structure.
Ajanta Pharma Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Ajanta Pharma Ltd.
- Mar 2026: 8.26%
- Dec 2025: 7.98%
- Sept 2025: 8.53%
- Jun 2025: 8.86%
- Mar 2025: 8.86%
FII holding in Ajanta Pharma Ltd has increased recently, indicating rising foreign investor interest.
Ajanta Pharma Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 18.37%
- Dec 2025: 18.58%
- Sept 2025: 17.90%
- Jun 2025: 17.50%
- Mar 2025: 17.48%
DII holdings remain stable, reflecting steady institutional participation.
Ajanta Pharma Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 7.12%
- Dec 2025: 7.19%
- Sept 2025: 7.32%
- Jun 2025: 7.38%
- Mar 2025: 7.39%
Public holding remains stable with consistent retail participation.
Ajanta Pharma Ltd Government Holding
Government holding in Ajanta Pharma Ltd currently stands at 0.01%.
Government presence indicates institutional backing and regulatory confidence.
Ajanta Pharma Ltd Shareholding Analysis Summary
The Ajanta Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Ajanta Pharma Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Ajanta Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.